Our NEW 😍 #OpenAccess article on SILs from #cervix in an issue of Radiology and Oncology.
Does non-block, patchy p16 mean anything in the context of HSIL like atypia? What’s the role of NANOG, HPV E4, SOX11 in cervical #gynpath ?
➡️
https://t.co/jtx8DdSIVC
In some instances, MTC occurs alongside #papillary carcinoma—a combination documented in multiple studies! 📚
Additionally, normal or low serum calcitonin and carcinoembryonic antigen levels might suggest low-grade, non metastatic MTC. ⚖️ #CytoJ⬇️
https://t.co/fLrhGoQCTg
Bad news: adenocarcinoma cells from colorectal #cancer in #urine can be really subtle (and degenerated) in well differentiated cases or easily mistaken for HGUC in poorly differentiated ones. CDX2 #ICC helps. #Cytopath#CytoJ ⬇️
🫁☄️While PD-L1 has become routine in #cytopath for #lungcarcinoma, IDO2 remains largely unexplored. This #CytoJ study found that IDO2 #IHC staining (correlated to TILs) showed no significant difference between paired bronchoscopic biopsies and cell block preparations from BAL ⬇️
😘Please take a moment to share your thoughts on how you engage with #cytopath and #SoMe, and help us improve. Clear communication is 🔑⬇️
https://t.co/ikQqEPCwkk
16th century church in Upper Carniola, Slovenia.
During the Habsburg-Ottoman wars this hill was one of the strategic locations where signal bonfires were lit to inform people of incoming Ottoman raids.
🎓✨ After a grueling expedition through the jungles of research, I’ve finally unearthed my PhD treasure alive! 🏺💼 Like Indiana Jones I navigated every challenge, fueled by the soundtrack of love and support. Thank you for the music that kept me going! 🎶❤️
🧐🙋♀️ #OpenAccess study evaluated 112 cases of #endometrial#cytology on ThinPrep using the novel preparation technique. Samples showed high accuracy in detecting endometrial malignancies, even by inexperienced examiners using the Yokohama System.
#CytoJ ⬇️
https://t.co/BF8Sv4NWpl
📊🔍 A 5-year study on cervical #Pap smear peer review found the highest agreement in SIL categories and the lowest in ASC categories with differences in young/experienced #cytopaths . Collaboration is 🔑. 🤝🥸👧
#CytoJ ⬇️
https://t.co/qq8V71qBEG
Explore this review on #benign#lung#cytopath changes, like bronchial/reserve cell/type II pneumocyte hyperplasia, reparative and reactive changes, squamous metaplasia,… Not identifying 🐑 for 🐺 and vice versa can be the biggest challenge!
#CytoJ ⬇️
https://t.co/xhYhDqBJ9b
To learn more about the ESP position on Digital transformation, you are welcome to read our expert opinion paper, published at the Virchows Archiv journal: https://t.co/jBd2hxlz8P
@SpringerPath